Company News – Page 3 – NeRRe Therapeutics

May 03

NeRRe Therapeutics CEO, Dr Mary Kerr, interviewed at the 2017 Biotech Showcase by Mike Ward, Chief Content Officer at Datamonitor Healthcare & Scrip Intelligence

By Chris Adams Company News

https://youtu.be/jKnNBChS79A

Apr 26

NeRRe Therapeutics CEO, Dr Mary Kerr, will present at BioTrinity 2017, May 9th, London, UK, The title of the presentation is “NeRRe Therapeutics – a unique Neurokinin antagonist pipeline with the potential to return significant near-term value”

By Chris Adams Company News

NeRRe Therapeutics CEO, Dr Mary Kerr, will present at BioTrinity 2017, May 9th, London, UK, The title of the presentation is “NeRRe Therapeutics – a unique Neurokinin antagonist pipeline with…

Company News22

NeRRe Therapeutics CEO, Dr Mary Kerr, interviewed at the 2017 Biotech Showcase by Mike Ward, Chief Content Officer at Datamonitor Healthcare & Scrip Intelligence

NeRRe Therapeutics CEO, Dr Mary Kerr, will present at BioTrinity 2017, May 9th, London, UK, The title of the presentation is “NeRRe Therapeutics – a unique Neurokinin antagonist pipeline with the potential to return significant near-term value”

Recent Posts

Useful LInks